Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Serology Strategy for Epidemiological Studies Based on the Comparison of the Performance of Seven Different Test Systems - The Representative COVID-19 Cohort Munich

View ORCID ProfileLaura Olbrich, Noemi Castelletti, Yannik Schälte, Mercè Garí, Peter Pütz, Abhishek Bakuli, Michael Pritsch, Inge Kroidl, Elmar Saathoff, Jessica Michelle Guggenbuehl Noller, Volker Fingerle, Ronan Le Gleut, Leonard Gilberg, Isabel Brand, Philine Falk, Alisa Markgraf, Flora Deák, Friedrich Riess, Max Diefenbach, Tabea Eser, Franz Weinauer, Silke Martin, Ernst-Markus Quenzel, Marc Becker, Jürgen Durner, Philipp Girl, Katharina Müller, Katja Radon, Christiane Fuchs, Roman Wölfel, View ORCID ProfileJan Hasenauer, Michael Hoelscher, Andreas Wieser On behalf of the KoCo19-Study Team
doi: https://doi.org/10.1101/2021.01.13.21249735
Laura Olbrich
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
2Germany German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura Olbrich
Noemi Castelletti
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
3Institute of Radiation Medicine, Helmholtz Zentrum München, 85764 Neuherberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yannik Schälte
4Institute of Computational Biology, Helmholtz Zentrum München, 85764 Neuherberg, Germany
5Center for Mathematics, Technische Universität München, 85748 Garching, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mercè Garí
4Institute of Computational Biology, Helmholtz Zentrum München, 85764 Neuherberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Pütz
4Institute of Computational Biology, Helmholtz Zentrum München, 85764 Neuherberg, Germany
6Department of Business Administration and Economics, Bielefeld University, 33615 Bielefeld, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhishek Bakuli
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Pritsch
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inge Kroidl
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
2Germany German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elmar Saathoff
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
2Germany German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Michelle Guggenbuehl Noller
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Volker Fingerle
2Germany German Center for Infection Research (DZIF), partner site Munich, Germany
7Bavarian Health and Food Safety Authority (LGL)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronan Le Gleut
4Institute of Computational Biology, Helmholtz Zentrum München, 85764 Neuherberg, Germany
8Core Facility Statistical Consulting, Helmholtz Zentrum München, 85764 Neuherberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Gilberg
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Brand
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philine Falk
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alisa Markgraf
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Flora Deák
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Friedrich Riess
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Max Diefenbach
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tabea Eser
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franz Weinauer
9BRK-Blutspendedienst, 80336 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silke Martin
9BRK-Blutspendedienst, 80336 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernst-Markus Quenzel
9BRK-Blutspendedienst, 80336 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Becker
10Department of Conservative Dentistry and Periodontology, University Hospital, LMU Munich Ludwig-Maximilians- University of Munich, Goethestr. 70, 80336 Munich, Germany
11Laboratory Becker and colleagues, Führichstr. 70, 81671 München, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Durner
10Department of Conservative Dentistry and Periodontology, University Hospital, LMU Munich Ludwig-Maximilians- University of Munich, Goethestr. 70, 80336 Munich, Germany
11Laboratory Becker and colleagues, Führichstr. 70, 81671 München, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp Girl
2Germany German Center for Infection Research (DZIF), partner site Munich, Germany
12Bundeswehr Institute of Microbiology, 80937 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katharina Müller
2Germany German Center for Infection Research (DZIF), partner site Munich, Germany
12Bundeswehr Institute of Microbiology, 80937 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katja Radon
13Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, 80336 Munich, Germany
14Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany
15Comprehensive Pneumology Center (CPC) Munich, German Center for Lung Research (DZL), 80337 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christiane Fuchs
4Institute of Computational Biology, Helmholtz Zentrum München, 85764 Neuherberg, Germany
5Center for Mathematics, Technische Universität München, 85748 Garching, Germany
6Department of Business Administration and Economics, Bielefeld University, 33615 Bielefeld, Germany
8Core Facility Statistical Consulting, Helmholtz Zentrum München, 85764 Neuherberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roman Wölfel
2Germany German Center for Infection Research (DZIF), partner site Munich, Germany
12Bundeswehr Institute of Microbiology, 80937 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Hasenauer
4Institute of Computational Biology, Helmholtz Zentrum München, 85764 Neuherberg, Germany
5Center for Mathematics, Technische Universität München, 85748 Garching, Germany
16Faculty of Mathematics and Natural Sciences, University of Bonn, 53113 Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan Hasenauer
Michael Hoelscher
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
2Germany German Center for Infection Research (DZIF), partner site Munich, Germany
14Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Wieser
1Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
2Germany German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Wieser@mvp.lmu.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Serosurveys are essential to understand SARS-CoV-2 exposure and enable population-level surveillance, but currently available tests need further in-depth evaluation. We aimed to identify testing-strategies by comparing seven seroassays in a population-based cohort.

Methods We analysed 6,658 samples consisting of true-positives (n=193), true-negatives (n=1,091), and specimens of unknown status (n=5,374). For primary testing, we used Euroimmun-Anti-SARS-CoV-2-ELISA-IgA/IgG and Roche-Elecsys-Anti-SARS-CoV-2; and virus-neutralisation, GeneScript®cPass™, VIRAMED-SARS-CoV-2-ViraChip®, and Mikrogen-recomLine-SARS-CoV-2-IgG, including common-cold CoVs, for confirmatory testing. Statistical modelling generated optimised assay cut-off-thresholds.

Findings Sensitivity of Euroimmun-anti-S1-IgA was 64.8%, specificity 93.3%; for Euroimmun-anti-S1-IgG, sensitivity was 77.2/79.8% (manufacturer’s/optimised cut-offs), specificity 98.0/97.8%; Roche-anti-N sensitivity was 85.5/88.6%, specificity 99.8/99.7%. In true-positives, mean and median titres remained stable for at least 90-120 days after RT-PCR-positivity. Of true-positives with positive RT-PCR (<30 days), 6.7% did not mount detectable seroresponses. Virus-neutralisation was 73.8% sensitive, 100.0% specific (1:10 dilution). Neutralisation surrogate tests (GeneScript®cPass™, Mikrogen-recomLine-RBD) were >94.9% sensitive, >98.1% specific. Seasonality had limited effects; cross-reactivity with common-cold CoVs 229E and NL63 in SARS-CoV-2 true-positives was significant.

Conclusion Optimised cut-offs improved test performances of several tests. Non-reactive serology in true-positives was uncommon. For epidemiological purposes, confirmatory testing with virus-neutralisation may be replaced with GeneScript®cPass™ or recomLine-RBD. Head-to-head comparisons given here aim to contribute to the refinement of testing-strategies for individual and public health use.

Competing Interest Statement

AW and MH report personal fees and non-financial support from Roche Diagnostics, LO reports non-financial support from Roche Diagnostics. AW, MH and LO report non-financial support from Euroimmun, non-financial support from Viramed, non-financial support from Mikrogen. AW, MH, LO report grants, non-financial support and other from German Center for Infection Research DZIF, grants and non-financial support from Government of Bavaria, non-financial support from BMW, non-financial support from Munich Police, non-financial support and other from Accenture. JH reports grants from German Federal Ministry of Education and Research, during the conduct of the study. MH and AW report personal fees and non-financial support from Dr.Box-Betrobox, non-financial support from Dr. Becker MVZ during the conduct of the study. In addition, MH, AW, MB have a patent on a sample system for sputum diagnostics of SARS-CoV-2 pending. AW is involved in other different patents and companies not in relation with the serology of SARS-CoV-2. AW reports personal fees and other from Haeraeus Sensors, non-financial support from Bruker Daltonics, all of which are outside the submitted work, and non-related to SARS-CoV-2. MB is an authorized representative partner of Dr. Becker MVZ.

Clinical Trial

DRKS00021698

Clinical Protocols

https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-09164-9

Funding Statement

Bavarian State Ministry of Science and the Arts, University Hospital, LMU Munich, Helmholtz Centre Munich, University of Bonn, University of Bielefeld, German Ministry for Education and Research (proj. nr.: 01KI20271). Euroimmun, Roche, Mikrogen, Viramed provided kits and machines for analyses at discounted rates.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Ethics Commission of the Faculty of Medicine at LMU Munich, Germany (20-275-V).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • # KoCo19 study group: Emad Alamoudi, Jared Anderson, Valeria Baldassare, Maximilian Baumann, Marieke Behlen, Jessica Beyerl, Rebecca Böhnlein, Anna Brauer, Vera Britz, Jan Bruger, Friedrich Caroli, Lorenzo Contento, Alina Czwienzek, Emma Dech, Laura Dech, Jana Diekmannshemke, Anna Do, Gerhard Dobler, Ute Eberle, Judith Eckstein, Jonathan Frese, Stefanie Fischer, Felix Forster, Turid Frahnow, Günter Fröschl, Marius Gasser, Sonja Gauder, Otto Geisenberger, Christof Geldmacher, Kristina Gillig, Elias Golschan, Vitus Grauvogl, Celina Halfmann, Tim Haselwarter, Arlett Heiber, Matthias Herrmann, Stefan Hillmann, Christian Hinske, Janna Hoefflin, Tim Hofberger, Michael Höfinger, Larissa Hofmann, Sacha Horn, Kristina Huber, Christian Janke, Ursula Kappl, Charlotte Kiani, Isabel Klugherz, Norah Kreider, Arne Kroidl, Magdalena Lang, Clemens Lang, Silvan Lange, Ekaterina Lapteva, Michael Laxy, Reiner Leidl, Felix Lindner, Paula Matcau, Rebecca Mayrhofer, Anna-Maria Mekota, Hannah Müller, Dafni Metaxa, Katharina Müller, Leonie Pattard, Claire Pleimelding, Michel Pletschette, Stephan Prückner, Kerstin Puchinger, Konstantin Pusl, Elba Raimúndez, Julius Raschka, Jakob Reich, Camila Rothe, Raquel Rubio-Acero, Nicole Schäfer, Paul Schandelmaier, Lara Schneider, Sophie Schultz, Mirjam Schunk, Lars Schwettmann, Heidi Seibold, Peter Sothmann, Paul Stapor, Jeni Tang, Fabian Theis, Verena Thiel, Sophie Thiesbrummel, Eva Thumser, Niklas Thur, Julian Ullrich, Julia Waibel, Claudia Wallrauch, Simon Winter, Julia Wolff, Pia Wullinger, Tobias Würfel, Patrick Wustrow, Houda Yaqine, Sabine Zange, Eleftheria Zeggini, Thomas Zimmermann, Lea Zuche

Data Availability

Data are accessible subject to data protection regulations upon reasonable request to the corresponding author. To facilitate reproducibility and reuse, the code used to perform the analyses and generate the figures was made available on GitHub (https://github.com/koco19/lab_epi) and has been uploaded to ZENODO (http://doi.org/10.5281/zenodo.4300922, DOI 10.5281/zenodo.4300922) for long-term storage.

https://github.com/koco19/lab_epi

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 16, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Serology Strategy for Epidemiological Studies Based on the Comparison of the Performance of Seven Different Test Systems - The Representative COVID-19 Cohort Munich
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Serology Strategy for Epidemiological Studies Based on the Comparison of the Performance of Seven Different Test Systems - The Representative COVID-19 Cohort Munich
Laura Olbrich, Noemi Castelletti, Yannik Schälte, Mercè Garí, Peter Pütz, Abhishek Bakuli, Michael Pritsch, Inge Kroidl, Elmar Saathoff, Jessica Michelle Guggenbuehl Noller, Volker Fingerle, Ronan Le Gleut, Leonard Gilberg, Isabel Brand, Philine Falk, Alisa Markgraf, Flora Deák, Friedrich Riess, Max Diefenbach, Tabea Eser, Franz Weinauer, Silke Martin, Ernst-Markus Quenzel, Marc Becker, Jürgen Durner, Philipp Girl, Katharina Müller, Katja Radon, Christiane Fuchs, Roman Wölfel, Jan Hasenauer, Michael Hoelscher, Andreas Wieser
medRxiv 2021.01.13.21249735; doi: https://doi.org/10.1101/2021.01.13.21249735
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A Serology Strategy for Epidemiological Studies Based on the Comparison of the Performance of Seven Different Test Systems - The Representative COVID-19 Cohort Munich
Laura Olbrich, Noemi Castelletti, Yannik Schälte, Mercè Garí, Peter Pütz, Abhishek Bakuli, Michael Pritsch, Inge Kroidl, Elmar Saathoff, Jessica Michelle Guggenbuehl Noller, Volker Fingerle, Ronan Le Gleut, Leonard Gilberg, Isabel Brand, Philine Falk, Alisa Markgraf, Flora Deák, Friedrich Riess, Max Diefenbach, Tabea Eser, Franz Weinauer, Silke Martin, Ernst-Markus Quenzel, Marc Becker, Jürgen Durner, Philipp Girl, Katharina Müller, Katja Radon, Christiane Fuchs, Roman Wölfel, Jan Hasenauer, Michael Hoelscher, Andreas Wieser
medRxiv 2021.01.13.21249735; doi: https://doi.org/10.1101/2021.01.13.21249735

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (419)
  • Anesthesia (97)
  • Cardiovascular Medicine (895)
  • Dentistry and Oral Medicine (167)
  • Dermatology (101)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (404)
  • Epidemiology (8757)
  • Forensic Medicine (4)
  • Gastroenterology (403)
  • Genetic and Genomic Medicine (1856)
  • Geriatric Medicine (176)
  • Health Economics (386)
  • Health Informatics (1283)
  • Health Policy (642)
  • Health Systems and Quality Improvement (490)
  • Hematology (206)
  • HIV/AIDS (389)
  • Infectious Diseases (except HIV/AIDS) (10535)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (217)
  • Neurology (1747)
  • Nursing (100)
  • Nutrition (265)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (458)
  • Oncology (961)
  • Ophthalmology (279)
  • Orthopedics (107)
  • Otolaryngology (174)
  • Pain Medicine (117)
  • Palliative Medicine (41)
  • Pathology (263)
  • Pediatrics (556)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (218)
  • Psychiatry and Clinical Psychology (1840)
  • Public and Global Health (3971)
  • Radiology and Imaging (650)
  • Rehabilitation Medicine and Physical Therapy (341)
  • Respiratory Medicine (532)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (165)
  • Surgery (196)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (79)